Dr. Mason Marks advises clients on state and federal controlled substance regulation and licensing. He is a law professor at the University of New Hampshire Franklin Pierce School of Law, a Senior Fellow at the Petrie-Flom Center at Harvard Law School, and an affiliated fellow at the Information Society Project at Yale Law School.
A resident of Portland, Oregon, Mason divides his time between New England and the Pacific Northwest. He enjoys travel, hiking, and exploring the Oregon wilderness.
Public and scientific interest in psychedelics such as psilocybin and MDMA is expanding. Once off-limits because of federal prohibition, a trickle of research from the 1990s has grown into a stream. But despite increasing acceptance by the public, and commercial investment in psychedelic therapies, aging federal laws stem the flow of vital research. Psilocybin, a
